Histological and immunohistochemical features and genetic alterations in the malignant progression of giant cell tumor of bone: a possible association with TP53 mutation and loss of H3K27 trimethylation-Reference-Cited by-同舟云学术

Histological and immunohistochemical features and genetic alterations in the malignant progression of giant cell tumor of bone: a possible association with TP53 mutation and loss of H3K27 trimethylation

Published:2021-11-16 Issue: Volume: Page:
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Ishihara Shin,Yamamoto Hidetaka^ORCID,Iwasaki Takeshi,Toda Yu,Yamamoto Takeo,Yoshimoto Masato,Ito Yoshihiro,Susuki Yousuke,Kawaguchi Kengo,Kinoshita Izumi,Yamada Yuichi,Kohashi Kenichi,Fujiwara Toshifumi,Setsu Nokitaka,Endo Makoto,Matsumoto Yoshihiro,Kakuda Yuko,Nakashima Yasuharu,Oda Yoshinao

Funder

MEXT | Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

https://www.nature.com/articles/s41379-021-00972-x.pdf

Reference32 articles.

1. WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. Lyon(France): International Agency for Research on Cancer, 2020

2. Behjati, S. et al. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet 45, 1479–1482 (2013).

3. Yamamoto, H., Ishihara, S., Toda, Y. & Oda, Y. Histone H3.3 mutation in giant cell tumor of bone: an update in pathology. Med Mol Morphol 53, 1–6 (2020).